An analysis of patient records suggests that mRNA covid-19 vaccines boost the immune response to cancerous tumours when given ...

Patients with cancer who received mRNA-based COVID vaccines within 100 days of starting immune checkpoint therapy were twice ...

Researchers found that among cancer patients getting immunotherapy, those who got an mRNA Covid vaccine within 100 days ...

A new study suggests that these vaccines might boost the effects of immunotherapy drugs, perhaps by alerting the immune ...

Discover whether Moderna or BioNTech offers better long-term investment potential as both pivot from COVID-19 to innovative ...

A multi-institutional team led by University of Washington scientists have engineered a new vaccine platform combining mRNA ...

Professor from the Faculty of Medicine in Kragujevac Vladimir Jakovljevic said today that cooperation between Serbian and ...

Then, demand for its COVID-19 vaccine started to diminish. As hospitals resumed normal operations and anti-vaccine sentiment ...

Groundbreaking Study Raises Serious Concerns About COVID mRNA Vaccine Safety** A recent peer-reviewed study has emerged that scrutinizes the safety and implications of COVID-19 ...

It’s that time of year when the leaves are turning golden, there’s a chill in the air and the threat of respiratory viruses ...

Moderna faces significant uncertainty ahead of Q3 earnings, with heavy reliance on COVID vaccine revenues and limited ...

From Elon Musk and Satya Nadella to the co-founder of Moderna, it’s not just tycoons in Silicon Valley who have benefited ...